AGIO
NASDAQ · Biotechnology
Agios Pharmaceuticals Inc
$31.33
+1.92 (+6.53%)
Open$29.54
Previous Close$29.41
Day High$31.44
Day Low$28.93
52W High$46.00
52W Low$22.24
Volume—
Avg Volume1.42M
Market Cap1.69B
P/E Ratio—
EPS$-7.01
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
-65.3% upside
Current
$31.33
$31.33
Target
$10.87
$10.87
$8.41
$10.87 avg
$14.57
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 50.13M | 32.14M | 198.27M |
| Net Income | -382,970,441 | -220,986,982 | -11,344,752 |
| Profit Margin | -764.0% | -725.8% | -5.7% |
| EBITDA | -433,227,109 | -263,874,946 | -15,767,673 |
| Free Cash Flow | — | — | -7,306,109 |
| Rev Growth | +56.0% | +56.0% | -2.9% |
| Debt/Equity | — | — | 0.24 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $293.30 | +0.68% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $463.45 | +0.66% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $169.25 | +1.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $549.39 | +0.42% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $922.99 | +2.06% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.52 | +0.37% | 7.7 | 20.98B |